RE:RE:RE:Trucchio @Wainwright...Hey Fox I can't see who you're arguing with but the Sigilon deal is only 35M upfront and seeing as Lily already owned about 9% only costs them 30M net, with milestone for roughly another 300M net. So yeah their shares jumped from just under 4$ to low 20's on the annoucement but if were talking about such low numbers with ONC, it would be something along the lines of a partnership not a buyout. Not saying I wouldn't mind a 5-600% premium lol but I'd be mighty disapointed in that premium for a buyout. But there is a big difference with a company throwing around 30M in a company they're already invested in so hopefully we start getting some traction once the Pancan trial is detailed. I'm holding here until we see a business plan sooner than later but good luck.